Literature DB >> 32441048

Repigmentation of acrofacial vitiligo with subcutaneous tildrakizumab.

Rebekka Jerjen1, Ameshin Moodley1,2, Rodney Sinclair1.   

Abstract

Entities:  

Year:  2020        PMID： 32441048     DOI： 10.1111/ajd.13346

Source DB:  PubMed          Journal:  Australas J Dermatol        ISSN： 0004-8380            Impact factor:   2.875


× No keyword cloud information.
  1 in total

1.  Onset of vitiligo in a psoriasis patient on ixekizumab.

Authors:  Claudio Marasca; Luigi Fornaro; Fabrizio Martora; Vincenzo Picone; Gabriella Fabbrocini; Matteo Megna
Journal:  Dermatol Ther       Date:  2021-09-02       Impact factor: 3.858
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.